Primary antibodies included: Anti-Shh (Abcam, Cambridge, UK), anti-Gli1 antibody (Abcam), anti-Foxm1 antibody (Abcam), anti-β-catenin antibody (Cell Signaling Technology, MA, USA), anti-E-Cadherin antibody (Cell Signaling Technology), anti-vimentin antibody (Cell Signaling Technology), anti-F-actin antibody (Abcam) and anti-β-actin antibody (Thermo Fisher Scientific, MA, USA). Secondary antibodies included: HRP-labeled goat anti-rabbit IgG (Abcam) and HRP-labeled goat anti-mouse IgG (Abcam). All the primary antibodies were diluted to 1:1000. The secondary antibodies were diluted to 1:5000.
Anti foxm1 antibody
Anti-FOXM1 antibody is a primary antibody that specifically binds to and detects the FOXM1 protein. FOXM1 is a transcription factor that plays a key role in cell proliferation, cell cycle regulation, and tumor development. This antibody can be used in various applications, such as Western blotting, immunohistochemistry, and immunofluorescence, to study the expression and localization of FOXM1 in biological samples.
Lab products found in correlation
5 protocols using anti foxm1 antibody
Curcumin Regulates Gastric Cancer Cell Signaling
Primary antibodies included: Anti-Shh (Abcam, Cambridge, UK), anti-Gli1 antibody (Abcam), anti-Foxm1 antibody (Abcam), anti-β-catenin antibody (Cell Signaling Technology, MA, USA), anti-E-Cadherin antibody (Cell Signaling Technology), anti-vimentin antibody (Cell Signaling Technology), anti-F-actin antibody (Abcam) and anti-β-actin antibody (Thermo Fisher Scientific, MA, USA). Secondary antibodies included: HRP-labeled goat anti-rabbit IgG (Abcam) and HRP-labeled goat anti-mouse IgG (Abcam). All the primary antibodies were diluted to 1:1000. The secondary antibodies were diluted to 1:5000.
Immunohistochemical Analysis of Cancer Protein Expression
Protein Analysis in HUVECs
Antibodies and Knockdown Analysis
For Prx3 and FoxM1 knockdown, siRNAs (Prx3: 5′-AAGCCAAGTCCAGCTGCTTCC-3′, FoxM1: 5′-CTCTTCTCCCTCAGATATA-3′) were constructed based on the Prx3 and FoxM1 sequences, and exhibited > 80% knockdown efficiencies. For Prx3 overexpression, Ishikawa cells were transfected with 6 μg pCGN-HA or pCGN-HA-Prx3 for 48 hours using Lipofectamine LTX (Invitrogen, Carlsbad, CA) following the manufacturer's protocols, and then doxorubicin was treated with the indicated dosage for 24 hours. The transfected cells were harvested and subjected to western blotting with anti-PARP, anti-HA, and anti-tubulin antibodies.
FOXM1 Subcellular Localization in Huh7 Cells
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!